RedHill Biopharma reported $2.69M in EBITDA for its fiscal quarter ending in June of 2023.


Ebitda Change Date
Clal Biotechnology ILS -5295000 2.09M Dec/2022
Compugen -8429000 946K Jun/2025
Cronos Group USD 1.69M 2.75M Jun/2025
RedHill Biopharma USD 2.69M 108.46M Jun/2023